×
Choose Speciality

EXPLORE!

LOGIN

By signing up or signing in to eMediNexus, you consent to eMediNexus collecting and using your personal data in accordance with our Privacy Policy. We are committed to safeguarding your information and ensuring the highest standards of data protection. Your trust and privacy are of utmost importance to us.

eMediQuiz

  925 Views

eMediNexus    08 February 2018

In patients with stable cardiovascular disease at very high risk for CVD events (expected 10-year event rate of greater than 25 percent), such as those in the proposed NCEP guidelines, start high-intensity statin therapy plus a ………………rather than targeting a goal LDL-C.

  1. PCSK9-ab
  2. Ezetimibe
  3. Fenofibrate
  4. Plasmapheresis

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.